MyAllies News
Breaking
Regulatory
World
Technology
Business
Politics
Entertainment
Health
Sports
Topics
PROSERA drug
The latest news about PROSERA drug: headlines, AI summaries and the full story from every source.
Gossamer Bio Targets NDA Filing for Seralutinib in September 2026 with Potential Approval by Q3 2027
Seeking Alpha ยท
May 18, 2026, 22:11 UTC